DUBLIN--(BUSINESS WIRE)--The "Narcolepsy- Market Insight, Epidemiology and Market Forecast - 2027" drug pipelines has been added to ResearchAndMarkets.com's offering.
This report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Narcolepsy in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.
The report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Narcolepsy from 2016 to 2027 segmented by seven major markets. The report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.
Insights
- Patient Population
- Therapeutic Approaches
- Pipeline Analysis
- Market Size and Trends
- Market Opportunities
- Impact of upcoming Therapies
Scope
- 10 Year Forecast
- 7MM Coverage
- Epidemiology Segmentation
- Drugs Uptake
- Highly Analyzed Market
- Key Cross Competition
Assessment
- Current Treatment Practices
- Unmet Needs
- Detailed Pipeline Product Profiles
- Market Attractiveness
- Market Drivers and Barriers
Companies Mentioned
- NLS Pharma - Jazz Pharma
- Avadel - Sanofi - Aventis
- Taisho Pharmaceuticals
- Balance Therapeutics
- Bioprojet
- Theranexus
Key Topics Covered
1. Key Insights
2. Narcolepsy Market Overview at a Glance
3. Disease Background and Overview: Narcolepsy
4. Epidemiology and Patient Population
5. 7MM Total Prevalent Patient Population of Narcolepsy
6. Current Treatment and Medical Practices
7. Unmet Needs
8. Marketed drugs
9. Other Narcoleptics
10. Emerging Drugs
11. Narcolepsy: 7 Major Market Analysis
12. Narcolepsy: 7 Major Market Outlook
13. Market Size of Narcolepsy in 7MM
14. Market Outlook by Country
15. Market Drivers
16. Market Barriers
17. Appendix
18. Report Methodology
19. Capabilities
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/nf577q/global_narcolepsy?w=4
